Regulation of mRNA Translation in Neurons—A Matter of Life and Death

Neuron

Volumn 96, Issue 3, 2017, Pages 616-637

  Kapur, Mridu ^a   Monaghan, Caitlin E ^a   Ackerman, Susan L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

aminoacyl tRNA synthetase; angiogenin; eIF2 phosphorylation; GTPBP2; integrated stress response; mistranslation; mTOR; n Tr20; n Trtct5; repeat associated non ATG translation

Indexed keywords

AMINO ACID TRANSFER RNA LIGASE; ELONGATION FACTOR 1ALPHA; MESSENGER RNA; TRANSFER RNA;

ALZHEIMER DISEASE; BINDING SITE; DEGENERATIVE DISEASE; EEF1A GENE; ENZYME ACTIVITY; GENE EXPRESSION; GENE LOSS; GENE MUTATION; GENETIC ASSOCIATION; HOMOZYGOSITY; HUMAN; LONG TERM DEPRESSION; LONG TERM POTENTIATION; NERVE CELL; NEUROPATHOLOGY; NUCLEOTIDE REPEAT; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; RNA BINDING; RNA CLEAVAGE; RNA PROCESSING; TRANSLATION ELONGATION; TRANSLATION REGULATION; TRANSLATION TERMINATION; TRNA AMINOACYLATION; WHOLE EXOME SEQUENCING; ANIMAL; CELL DEATH; CYTOPLASM; GENETICS; METABOLISM; PHYSIOLOGY; PROTEIN SYNTHESIS;

ANIMALS; CELL DEATH; CYTOPLASM; HUMANS; NEURODEGENERATIVE DISEASES; NEURONS; PROTEIN BIOSYNTHESIS; RNA, MESSENGER;

EID: 85032798286     PISSN: 08966273     EISSN: 10974199     Source Type: Journal    
DOI: 10.1016/j.neuron.2017.09.057     Document Type: Review

References (240)

1. Abbasi-Moheb, L., Mertel, S., Gonsior, M., Nouri-Vahid, L., Kahrizi, K., Cirak, S., Wieczorek, D., Motazacker, M.M., Esmaeeli-Nieh, S., Cremer, K., et al. Mutations in NSUN2 cause autosomal-recessive intellectual disability. Am. J. Hum. Genet. 90 (2012), 847–855.
2. Abbott, C.M., Newbery, H.J., Squires, C.E., Brownstein, D., Griffiths, L.A., Soares, D.C., eEF1A2 and neuronal degeneration. Biochem. Soc. Trans. 37 (2009), 1293–1297.
3. Abbott, J.A., Francklyn, C.S., Robey-Bond, S.M., Transfer RNA and human disease. Front. Genet., 5, 2014, 158.
4. Andreou, A.Z., Harms, U., Klostermeier, D., eIF4B stimulates eIF4A ATPase and unwinding activities by direct interaction through its 7-repeats region. RNA Biol. 14 (2017), 113–123.
5. Aparicio-Erriu, I.M., Prehn, J.H.M., Molecular mechanisms in amyotrophic lateral sclerosis: The role of angiogenin, a secreted RNase. Front. Neurosci., 6, 2012, 167.
6. Aronin, N., Chase, K., Young, C., Sapp, E., Schwarz, C., Matta, N., Kornreich, R., Landwehrmeyer, B., Bird, E., Beal, M.F., et al. CAG expansion affects the expression of mutant Huntingtin in the Huntington's disease brain. Neuron 15 (1995), 1193–1201.
7. Ash, P.E.A., Bieniek, K.F., Gendron, T.F., Caulfield, T., Lin, W.-L., Dejesus-Hernandez, M., van Blitterswijk, M.M., Jansen-West, K., Paul, J.W. 3rd, Rademakers, R., et al. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron 77 (2013), 639–646.
8. Azmanov, D.N., Siira, S.J., Chamova, T., Kaprelyan, A., Guergueltcheva, V., Shearwood, A.J., Liu, G., Morar, B., Rackham, O., Bynevelt, M., et al. Transcriptome-wide effects of a POLR3A gene mutation in patients with an unusual phenotype of striatal involvement. Hum. Mol. Genet. 25 (2016), 4302–4314.
9. Bando, Y., Onuki, R., Katayama, T., Manabe, T., Kudo, T., Taira, K., Tohyama, M., Double-strand RNA dependent protein kinase (PKR) is involved in the extrastriatal degeneration in Parkinson's disease and Huntington's disease. Neurochem. Int. 46 (2005), 11–18.
10. Bañez-Coronel, M., Ayhan, F., Tarabochia, A.D., Zu, T., Perez, B.A., Tusi, S.K., Pletnikova, O., Borchelt, D.R., Ross, C.A., Margolis, R.L., et al. RAN translation in Huntington disease. Neuron 88 (2015), 667–677.
11. Barbosa, C., Peixeiro, I., Romão, L., Gene expression regulation by upstream open reading frames and human disease. PLoS Genet., 9, 2013, e1003529.
12. Beckelman, B.C., Day, S., Zhou, X., Donohue, M., Gouras, G.K., Klann, E., Keene, C.D., Ma, T., Dysregulation of elongation factor 1A expression is correlated with synaptic plasticity impairments in Alzheimer's disease. J. Alzheimers Dis. 54 (2016), 669–678.
13. Beckelman, B.C., Zhou, X., Keene, C.D., Ma, T., Impaired eukaryotic elongation factor 1A Expression in Alzheimer's disease. Neurodegener. Dis. 16 (2016), 39–43.
14. Bednářová A., Hanna, M., Durham, I., VanCleave, T., England, A., Chaudhuri, A., Krishnan, N., Lost in translation: Defects in transfer RNA modifications and neurological disorders. Front. Mol. Neurosci., 10, 2017, 135.
15. Bengtson, M.H., Joazeiro, C.A.P., Role of a ribosome-associated E3 ubiquitin ligase in protein quality control. Nature 467 (2010), 470–473.
16. Bernard, G., Chouery, E., Putorti, M.L., Tétreault, M., Takanohashi, A., Carosso, G., Clément, I., Boespflug-Tanguy, O., Rodriguez, D., Delague, V., et al. Mutations of POLR3A encoding a catalytic subunit of RNA polymerase Pol III cause a recessive hypomyelinating leukodystrophy. Am. J. Hum. Genet. 89 (2011), 415–423.
17. Bierhals, T., Korenke, G.C., Uyanik, G., Kutsche, K., Pontocerebellar hypoplasia type 2 and TSEN2: Review of the literature and two novel mutations. Eur. J. Med. Genet. 56 (2013), 325–330.
18. Blanco, S., Dietmann, S., Flores, J.V., Hussain, S., Kutter, C., Humphreys, P., Lukk, M., Lombard, P., Treps, L., Popis, M., et al. Aberrant methylation of tRNAs links cellular stress to neuro-developmental disorders. EMBO J. 33 (2014), 2020–2039.
19. Boczonadi, V., Horvath, R., Mitochondria: Impaired mitochondrial translation in human disease. Int. J. Biochem. Cell Biol. 48 (2014), 77–84.
20. Boeynaems, S., Bogaert, E., Michiels, E., Gijselinck, I., Sieben, A., Jovičić A., De Baets, G., Scheveneels, W., Steyaert, J., Cuijt, I., et al. Drosophila screen connects nuclear transport genes to DPR pathology in c9ALS/FTD. Sci. Rep., 6, 2016, 20877.
21. Brandman, O., Hegde, R.S., Ribosome-associated protein quality control. Nat. Struct. Mol. Biol. 23 (2016), 7–15.
22. Breuss, M.W., Sultan, T., James, K.N., Rosti, R.O., Scott, E., Musaev, D., Furia, B., Reis, A., Sticht, H., Al-Owain, M., et al. Autosomal-recessive mutations in the tRNA splicing endonuclease subunit TSEN15 cause pontocerebellar hypoplasia and progressive microcephaly. Am. J. Hum. Genet. 99 (2016), 228–235.
23. Buffington, S.A., Huang, W., Costa-Mattioli, M., Translational control in synaptic plasticity and cognitive dysfunction. Annu. Rev. Neurosci. 37 (2014), 17–38.
24. Bugiani, M., Boor, I., Powers, J.M., Scheper, G.C., van der Knaap, M.S., Leukoencephalopathy with vanishing white matter: A review. J. Neuropathol. Exp. Neurol. 69 (2010), 987–996.
25. Carr-Schmid, A., Durko, N., Cavallius, J., Merrick, W.C., Kinzy, T.G., Mutations in a GTP-binding motif of eukaryotic elongation factor 1A reduce both translational fidelity and the requirement for nucleotide exchange. J. Biol. Chem. 274 (1999), 30297–30302.
26. Chakraborty, P.K., Schmitz-Abe, K., Kennedy, E.K., Mamady, H., Naas, T., Durie, D., Campagna, D.R., Lau, A., Sendamarai, A.K., Wiseman, D.H., et al. Mutations in TRNT1 cause congenital sideroblastic anemia with immunodeficiency, fevers, and developmental delay (SIFD). Blood 124 (2014), 2867–2871.
27. Chambers, D.M., Peters, J., Abbott, C.M., The lethal mutation of the mouse wasted (wst) is a deletion that abolishes expression of a tissue-specific isoform of translation elongation factor 1alpha, encoded by the Eef1a2 gene. Proc. Natl. Acad. Sci. USA 95 (1998), 4463–4468.
28. Chang, R.C.-C., Suen, K.-C., Ma, C.-H., Elyaman, W., Ng, H.-K., Hugon, J., Involvement of double-stranded RNA-dependent protein kinase and phosphorylation of eukaryotic initiation factor-2alpha in neuronal degeneration. J. Neurochem. 83 (2002), 1215–1225.
29. Chang, R.C.C., Wong, A.K.Y., Ng, H.-K., Hugon, J., Phosphorylation of eukaryotic initiation factor-2alpha (eIF2alpha) is associated with neuronal degeneration in Alzheimer's disease. Neuroreport 13 (2002), 2429–2432.
30. Chen, M.L., Wu, R.M., Tai, C.H., Lin, C.H., Mutational analysis of angiogenin gene in Parkinson's disease. PLoS ONE, 9, 2014, e112661.
31. Choe, Y.-J., Park, S.-H., Hassemer, T., Körner, R., Vincenz-Donnelly, L., Hayer-Hartl, M., Hartl, F.U., Failure of RQC machinery causes protein aggregation and proteotoxic stress. Nature 531 (2016), 191–195.
32. Chu, J., Hong, N.A., Masuda, C.A., Jenkins, B.V., Nelms, K.A., Goodnow, C.C., Glynne, R.J., Wu, H., Masliah, E., Joazeiro, C.A.P., Kay, S.A., A mouse forward genetics screen identifies LISTERIN as an E3 ubiquitin ligase involved in neurodegeneration. Proc. Natl. Acad. Sci. USA 106 (2009), 2097–2103.
33. Ciesiolka, A., Jazurek, M., Drazkowska, K., Krzyzosiak, W.J., Structural Characteristics of Simple RNA Repeats Associated with Disease and their Deleterious Protein Interactions. Front. Cell. Neurosci., 11, 2017, 97.
34. Corrado, L., Battistini, S., Penco, S., Bergamaschi, L., Testa, L., Ricci, C., Giannini, F., Greco, G., Patrosso, M.C., Pileggi, S., et al. Variations in the coding and regulatory sequences of the angiogenin (ANG) gene are not associated to ALS (amyotrophic lateral sclerosis) in the Italian population. J. Neurol. Sci. 258 (2007), 123–127.
35. Costa-Mattioli, M., Gobert, D., Harding, H., Herdy, B., Azzi, M., Bruno, M., Bidinosti, M., Ben Mamou, C., Marcinkiewicz, E., Yoshida, M., et al. Translational control of hippocampal synaptic plasticity and memory by the eIF2alpha kinase GCN2. Nature 436 (2005), 1166–1173.
36. Costa-Mattioli, M., Gobert, D., Stern, E., Gamache, K., Colina, R., Cuello, C., Sossin, W., Kaufman, R., Pelletier, J., Rosenblum, K., et al. eIF2alpha phosphorylation bidirectionally regulates the switch from short- to long-term synaptic plasticity and memory. Cell 129 (2007), 195–206.
37. Costa-Mattioli, M., Sossin, W.S., Klann, E., Sonenberg, N., Translational control of long-lasting synaptic plasticity and memory. Neuron 61 (2009), 10–26.
38. Czech, A., Wende, S., Mörl, M., Pan, T., Ignatova, Z., Reversible and rapid transfer-RNA deactivation as a mechanism of translational repression in stress. PLoS Genet., 9, 2013, e1003767.
39. Das, I., Krzyzosiak, A., Schneider, K., Wrabetz, L., D'Antonio, M., Barry, N., Sigurdardottir, A., Bertolotti, A., Preventing proteostasis diseases by selective inhibition of a phosphatase regulatory subunit. Science 348 (2015), 239–242.
40. Davidson, Y.S., Barker, H., Robinson, A.C., Thompson, J.C., Harris, J., Troakes, C., Smith, B., Al-Saraj, S., Shaw, C., Rollinson, S., et al. Brain distribution of dipeptide repeat proteins in frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72. Acta Neuropathol. Commun., 2, 2014, 70.
41. Davies, J.E., Rubinsztein, D.C., Polyalanine and polyserine frameshift products in Huntington's disease. J. Med. Genet. 43 (2006), 893–896.
42. de Ligt, J., Willemsen, M.H., van Bon, B.W.M., Kleefstra, T., Yntema, H.G., Kroes, T., Vulto-van Silfhout, A.T., Koolen, D.A., de Vries, P., Gilissen, C., et al. Diagnostic exome sequencing in persons with severe intellectual disability. N. Engl. J. Med. 367 (2012), 1921–1929.
43. DeLuca, A.P., Whitmore, S.S., Barnes, J., Sharma, T.P., Westfall, T.A., Scott, C.A., Weed, M.C., Wiley, J.S., Wiley, L.A., Johnston, R.M., et al. Hypomorphic mutations in TRNT1 cause retinitis pigmentosa with erythrocytic microcytosis. Hum. Mol. Genet. 25 (2016), 44–56.
44. Dennis, M.D., Jefferson, L.S., Kimball, S.R., Role of p70S6K1-mediated phosphorylation of eIF4B and PDCD4 proteins in the regulation of protein synthesis. J. Biol. Chem. 287 (2012), 42890–42899.
45. Dever, T.E., Green, R., The elongation, termination, and recycling phases of translation in eukaryotes. Cold Spring Harb. Perspect. Biol., 4, 2012, a013706.
46. Devi, L., Ohno, M., Deletion of the eIF2α Kinase GCN2 fails to rescue the memory decline associated with Alzheimer's disease. PLoS ONE, 8, 2013, e77335.
47. Devi, L., Ohno, M., PERK mediates eIF2α phosphorylation responsible for BACE1 elevation, CREB dysfunction and neurodegeneration in a mouse model of Alzheimer's disease. Neurobiol. Aging 35 (2014), 2272–2281.
48. Dinman, J.D., Pathways to Specialized Ribosomes: The Brussels Lecture. J. Mol. Biol. 428:10 Pt B (2016), 2186–2194.
49. Dong, J., Qiu, H., Garcia-Barrio, M., Anderson, J., Hinnebusch, A.G., Uncharged tRNA activates GCN2 by displacing the protein kinase moiety from a bipartite tRNA-binding domain. Mol. Cell 6 (2000), 269–279.
50. Edvardson, S., Prunetti, L., Arraf, A., Haas, D., Bacusmo, J.M., Hu, J.F., Ta-Shma, A., Dedon, P.C., de Crécy-Lagard, V., Elpeleg, O., tRNA N6-adenosine threonylcarbamoyltransferase defect due to KAE1/TCS3 (OSGEP) mutation manifest by neurodegeneration and renal tubulopathy. Eur. J. Hum. Genet. 25 (2017), 545–551.
51. Farabaugh, P.J., Vimaladithan, A., Effect of frameshift-inducing mutants of elongation factor 1alpha on programmed +1 frameshifting in yeast. RNA 4 (1998), 38–46.
52. Fernández-Santiago, R., Hoenig, S., Lichtner, P., Sperfeld, A.D., Sharma, M., Berg, D., Weichenrieder, O., Illig, T., Eger, K., Meyer, T., et al. Identification of novel Angiogenin (ANG) gene missense variants in German patients with amyotrophic lateral sclerosis. J. Neurol. 256 (2009), 1337–1342.
53. Freibaum, B.D., Lu, Y., Lopez-Gonzalez, R., Kim, N.C., Almeida, S., Lee, K.-H., Badders, N., Valentine, M., Miller, B.L., Wong, P.C., et al. GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport. Nature 525 (2015), 129–133.
54. Fu, H., Feng, J., Liu, Q., Sun, F., Tie, Y., Zhu, J., Xing, R., Sun, Z., Zheng, X., Stress induces tRNA cleavage by angiogenin in mammalian cells. FEBS Lett. 583 (2009), 437–442.
55. Garcia-Esparcia, P., Hernández-Ortega, K., Koneti, A., Gil, L., Delgado-Morales, R., Castaño, E., Carmona, M., Ferrer, I., Altered machinery of protein synthesis is region- and stage-dependent and is associated with α-synuclein oligomers in Parkinson's disease. Acta Neuropathol. Commun., 3, 2015, 76.
56. Garcia-Esparcia, P., Sideris-Lampretsas, G., Hernandez-Ortega, K., Grau-Rivera, O., Sklaviadis, T., Gelpi, E., Ferrer, I., Altered mechanisms of protein synthesis in frontal cortex in Alzheimer disease and a mouse model. Am. J. Neurodegener. Dis. 6 (2017), 15–25.
57. Gaspar, C., Jannatipour, M., Dion, P., Laganière, J., Sequeiros, J., Brais, B., Rouleau, G.A., CAG tract of MJD-1 may be prone to frameshifts causing polyalanine accumulation. Hum. Mol. Genet. 9 (2000), 1957–1966.
58. Gendron, T.F., Bieniek, K.F., Zhang, Y.-J., Jansen-West, K., Ash, P.E.A., Caulfield, T., Daughrity, L., Dunmore, J.H., Castanedes-Casey, M., Chew, J., et al. Antisense transcripts of the expanded C9ORF72 hexanucleotide repeat form nuclear RNA foci and undergo repeat-associated non-ATG translation in c9FTD/ALS. Acta Neuropathol. 126 (2013), 829–844.
59. Gingold, H., Tehler, D., Christoffersen, N.R., Nielsen, M.M., Asmar, F., Kooistra, S.M., Christophersen, N.S., Christensen, L.L., Borre, M., Sørensen, K.D., et al. A dual program for translation regulation in cellular proliferation and differentiation. Cell 158 (2014), 1281–1292.
60. Girstmair, H., Saffert, P., Rode, S., Czech, A., Holland, G., Bannert, N., Ignatova, Z., Depletion of cognate charged transfer RNA causes translational frameshifting within the expanded CAG stretch in huntingtin. Cell Rep. 3 (2013), 148–159.
61. Gomez-Deza, J., Lee, Y.-B., Troakes, C., Nolan, M., Al-Sarraj, S., Gallo, J.-M., Shaw, C.E., Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration. Acta Neuropathol. Commun., 3, 2015, 38.
62. Gonskikh, Y., Polacek, N., Alterations of the translation apparatus during aging and stress response. Mech. Ageing Dev., 2017, 10.1016/j.mad.2017.04.003 Published online April 13, 2017.
63. Goodarzi, H., Nguyen, H.C.B., Zhang, S., Dill, B.D., Molina, H., Tavazoie, S.F., Modulated expression of specific tRNAs drives gene expression and cancer progression. Cell 165 (2016), 1416–1427.
64. Goodenbour, J.M., Pan, T., Diversity of tRNA genes in eukaryotes. Nucleic Acids Res. 34 (2006), 6137–6146.
65. Greenway, M.J., Andersen, P.M., Russ, C., Ennis, S., Cashman, S., Donaghy, C., Patterson, V., Swingler, R., Kieran, D., Prehn, J., et al. ANG mutations segregate with familial and “sporadic” amyotrophic lateral sclerosis. Nat. Genet. 38 (2006), 411–413.
66. Griesche, N., Schilling, J., Weber, S., Rohm, M., Pesch, V., Matthes, F., Auburger, G., Krauss, S., Regulation of mRNA translation by MID1: A common mechanism of expanded CAG repeat RNAs. Front. Cell. Neurosci., 10, 2016, 226.
67. Griffin, L.B., Sakaguchi, R., McGuigan, D., Gonzalez, M.A., Searby, C., Züchner, S., Hou, Y.-M., Antonellis, A., Impaired function is a common feature of neuropathy-associated glycyl-tRNA synthetase mutations. Hum. Mutat. 35 (2014), 1363–1371.
68. Guo, J.U., Bartel, D.P., RNA G-quadruplexes are globally unfolded in eukaryotic cells and depleted in bacteria. Science, 353, 2016 af5371.
69. Guo, M., Schimmel, P., Structural analyses clarify the complex control of mistranslation by tRNA synthetases. Curr. Opin. Struct. Biol. 22 (2012), 119–126.
70. Guo, M., Schimmel, P., Essential nontranslational functions of tRNA synthetases. Nat. Chem. Biol. 9 (2013), 145–153.
71. Gupta, R., Lan, M., Mojsilovic-Petrovic, J., Choi, W.H., Safren, N., Barmada, S., Lee, M.J., Kalb, R., The proline/arginine dipeptide from hexanucleotide repeat expanded C9ORF72 inhibits the proteasome. eNeuro, 4, 2017, 10.1523/ENEURO.0249-16.2017 Published online January 31, 2017.
72. Guydosh, N.R., Green, R., Dom34 rescues ribosomes in 3′ untranslated regions. Cell 156 (2014), 950–962.
73. Haghighat, A., Mader, S., Pause, A., Sonenberg, N., Repression of cap-dependent translation by 4E-binding protein 1: Competition with p220 for binding to eukaryotic initiation factor-4E. EMBO J. 14 (1995), 5701–5709.
74. Halliday, M., Radford, H., Sekine, Y., Moreno, J., Verity, N., le Quesne, J., Ortori, C.A., Barrett, D.A., Fromont, C., Fischer, P.M., et al. Partial restoration of protein synthesis rates by the small molecule ISRIB prevents neurodegeneration without pancreatic toxicity. Cell Death Dis., 6, 2015, e1672.
75. Halliday, M., Radford, H., Zents, K.A.M., Molloy, C., Moreno, J.A., Verity, N.C., Smith, E., Ortori, C.A., Barrett, D.A., Bushell, M., Mallucci, G.R., Repurposed drugs targeting eIF2α-P-mediated translational repression prevent neurodegeneration in mice. Brain 140 (2017), 1768–1783.
76. Hanada, T., Weitzer, S., Mair, B., Bernreuther, C., Wainger, B.J., Ichida, J., Hanada, R., Orthofer, M., Cronin, S.J., Komnenovic, V., et al. CLP1 links tRNA metabolism to progressive motor-neuron loss. Nature 495 (2013), 474–480.
77. He, F., Jacobson, A., Nonsense-mediated mRNA decay: Degradation of defective transcripts is only part of the story. Annu. Rev. Genet. 49 (2015), 339–366.
78. He, W., Bai, G., Zhou, H., Wei, N., White, N.M., Lauer, J., Liu, H., Shi, Y., Dumitru, C.D., Lettieri, K., et al. CMT2D neuropathy is linked to the neomorphic binding activity of glycyl-tRNA synthetase. Nature 526 (2015), 710–714.
79. Hekman, K.E., Yu, G.Y., Brown, C.D., Zhu, H., Du, X., Gervin, K., Undlien, D.E., Peterson, A., Stevanin, G., Clark, H.B., et al. A conserved eEF2 coding variant in SCA26 leads to loss of translational fidelity and increased susceptibility to proteostatic insult. Hum. Mol. Genet. 21 (2012), 5472–5483.
80. Hernández-Ortega, K., Garcia-Esparcia, P., Gil, L., Lucas, J.J., Ferrer, I., Altered machinery of protein synthesis in Alzheimer's: From the nucleolus to the ribosome. Brain Pathol. 26 (2016), 593–605.
81. Hinnebusch, A.G., The scanning mechanism of eukaryotic translation initiation. Annu. Rev. Biochem. 83 (2014), 779–812.
82. Holz, M.K., Ballif, B.A., Gygi, S.P., Blenis, J., mTOR and S6K1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events. Cell 123 (2005), 569–580.
83. Hoozemans, J.J.M., van Haastert, E.S., Eikelenboom, P., de Vos, R.A.I., Rozemuller, J.M., Scheper, W., Activation of the unfolded protein response in Parkinson's disease. Biochem. Biophys. Res. Commun. 354 (2007), 707–711.
84. Hoozemans, J.J.M., van Haastert, E.S., Nijholt, D.A.T., Rozemuller, A.J.M., Eikelenboom, P., Scheper, W., The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus. Am. J. Pathol. 174 (2009), 1241–1251.
85. Hoozemans, J.J.M., van Haastert, E.S., Nijholt, D.A.T., Rozemuller, A.J.M., Scheper, W., Activation of the unfolded protein response is an early event in Alzheimer's and Parkinson's disease. Neurodegener. Dis. 10 (2012), 212–215.
86. Hu, J.-H., Zhang, H., Wagey, R., Krieger, C., Pelech, S.L., Protein kinase and protein phosphatase expression in amyotrophic lateral sclerosis spinal cord. J. Neurochem. 85 (2003), 432–442.
87. Hughes, D., Atkins, J.F., Thompson, S., Mutants of elongation factor Tu promote ribosomal frameshifting and nonsense readthrough. EMBO J. 6 (1987), 4235–4239.
88. Ilieva, E.V., Ayala, V., Jové M., Dalfó E., Cacabelos, D., Povedano, M., Bellmunt, M.J., Ferrer, I., Pamplona, R., Portero-Otín, M., Oxidative and endoplasmic reticulum stress interplay in sporadic amyotrophic lateral sclerosis. Brain 130 (2007), 3111–3123.
89. Inui, T., Kobayashi, S., Ashikari, Y., Sato, R., Endo, W., Uematsu, M., Oba, H., Saitsu, H., Matsumoto, N., Kure, S., Haginoya, K., Two cases of early-onset myoclonic seizures with continuous parietal delta activity caused by EEF1A2 mutations. Brain Dev. 38 (2016), 520–524.
90. Ishiguro, T., Sato, N., Ueyama, M., Fujikake, N., Sellier, C., Kanegami, A., Tokuda, E., Zamiri, B., Gall-Duncan, T., Mirceta, M., et al. Regulatory Role of RNA Chaperone TDP-43 for RNA Misfolding and Repeat-Associated Translation in SCA31. Neuron 94 (2017), 108–124.e7.
91. Ishimura, R., Nagy, G., Dotu, I., Zhou, H., Yang, X.-L., Schimmel, P., Senju, S., Nishimura, Y., Chuang, J.H., Ackerman, S.L., RNA function. Ribosome stalling induced by mutation of a CNS-specific tRNA causes neurodegeneration. Science 345 (2014), 455–459.
92. Ishimura, R., Nagy, G., Dotu, I., Chuang, J.H., Ackerman, S.L., Activation of GCN2 kinase by ribosome stalling links translation elongation with translation initiation. eLife 5 (2016), 1–22.
93. Ivanov, P., Emara, M.M., Villen, J., Gygi, S.P., Anderson, P., Angiogenin-induced tRNA fragments inhibit translation initiation. Mol. Cell 43 (2011), 613–623.
94. Jaberi, E., Rohani, M., Shahidi, G.A., Nafissi, S., Arefian, E., Soleimani, M., Rasooli, P., Ahmadieh, H., Daftarian, N., KaramiNejadRanjbar, M., et al. Identification of mutation in GTPBP2 in patients of a family with neurodegeneration accompanied by iron deposition in the brain. Neurobiol. Aging 38 (2016), 216.e11–216.e18.
95. Jackson, R.J., Hellen, C.U.T., Pestova, T.V., The mechanism of eukaryotic translation initiation and principles of its regulation. Nat. Rev. Mol. Cell Biol. 11 (2010), 113–127.
96. Jackson, R.J., Hellen, C.U.T., Pestova, T.V., Termination and post-termination events in eukaryotic translation. Adv. Protein Chem. Struct. Biol. 86 (2012), 45–93.
97. Jennings, M.D., Pavitt, G.D., A new function and complexity for protein translation initiation factor eIF2B. Cell Cycle 13 (2014), 2660–2665.
98. Joazeiro, C.A.P., Ribosomal stalling during translation: Providing substrates for ribosome-associated protein quality control. Annu. Rev. Cell Dev. Biol. 33 (2017), 343–368.
99. Jovičić A., Mertens, J., Boeynaems, S., Bogaert, E., Chai, N., Yamada, S.B., Paul, J.W. 3rd, Sun, S., Herdy, J.R., Bieri, G., et al. Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS. Nat. Neurosci. 18 (2015), 1226–1229.
100. Kanekura, K., Yagi, T., Cammack, A.J., Mahadevan, J., Kuroda, M., Harms, M.B., Miller, T.M., Urano, F., Poly-dipeptides encoded by the C9ORF72 repeats block global protein translation. Hum. Mol. Genet. 25 (2016), 1803–1813.
101. Karaca, E., Weitzer, S., Pehlivan, D., Shiraishi, H., Gogakos, T., Hanada, T., Jhangiani, S.N., Wiszniewski, W., Withers, M., Campbell, I.M., et al., Baylor Hopkins Center for Mendelian Genomics. Human CLP1 mutations alter tRNA biogenesis, affecting both peripheral and central nervous system function. Cell 157 (2014), 636–650.
102. Kearse, M.G., Green, K.M., Krans, A., Rodriguez, C.M., Linsalata, A.E., Goldstrohm, A.C., Todd, P.K., CGG repeat-associated non-AUG translation utilizes a cap-dependent scanning mechanism of initiation to produce toxic proteins. Mol. Cell 62 (2016), 314–322.
103. Kieran, D., Sebastia, J., Greenway, M.J., King, M.A., Connaughton, D., Concannon, C.G., Fenner, B., Hardiman, O., Prehn, J.H.M., Control of motoneuron survival by angiogenin. J. Neurosci. 28 (2008), 14056–14061.
104. Kim, H.-S., Choi, Y., Shin, K.-Y., Joo, Y., Lee, Y.-K., Jung, S.Y., Suh, Y.-H., Kim, J.-H., Swedish amyloid precursor protein mutation increases phosphorylation of eIF2alpha in vitro and in vivo. J. Neurosci. Res. 85 (2007), 1528–1537.
105. Kim, H.J., Raphael, A.R., LaDow, E.S., McGurk, L., Weber, R.A., Trojanowski, J.Q., Lee, V.M., Finkbeiner, S., Gitler, A.D., Bonini, N.M., Therapeutic modulation of eIF2α phosphorylation rescues TDP-43 toxicity in amyotrophic lateral sclerosis disease models. Nat. Genet. 46 (2014), 152–160.
106. Kirchner, S., Cai, Z., Rauscher, R., Kastelic, N., Anding, M., Czech, A., Kleizen, B., Ostedgaard, L.S., Braakman, I., Sheppard, D.N., Ignatova, Z., Alteration of protein function by a silent polymorphism linked to tRNA abundance. PLoS Biol., 15, 2017, e2000779.
107. Klann, E., Dever, T.E., Biochemical mechanisms for translational regulation in synaptic plasticity. Nat. Rev. Neurosci. 5 (2004), 931–942.
108. Kodera, H., Osaka, H., Iai, M., Aida, N., Yamashita, A., Tsurusaki, Y., Nakashima, M., Miyake, N., Saitsu, H., Matsumoto, N., Mutations in the glutaminyl-tRNA synthetase gene cause early-onset epileptic encephalopathy. J. Hum. Genet. 60 (2015), 97–101.
109. Köhler, C., Dinekov, M., Götz, J., Granulovacuolar degeneration and unfolded protein response in mouse models of tauopathy and Aβ amyloidosis. Neurobiol. Dis. 71 (2014), 169–179.
110. Komara, M., Al-Shamsi, A.M., Ben-Salem, S., Ali, B.R., Al-Gazali, L., A novel single-nucleotide deletion (c.1020delA) in NSUN2 causes intellectual disability in an Emirati child. J. Mol. Neurosci. 57 (2015), 393–399.
111. Krans, A., Kearse, M.G., Todd, P.K., Repeat-associated non-AUG translation from antisense CCG repeats in fragile X tremor/ataxia syndrome. Ann. Neurol. 80 (2016), 871–881.
112. Krauss, S., Griesche, N., Jastrzebska, E., Chen, C., Rutschow, D., Achmüller, C., Dorn, S., Boesch, S.M., Lalowski, M., Wanker, E., et al. Translation of HTT mRNA with expanded CAG repeats is regulated by the MID1-PP2A protein complex. Nat. Commun., 4, 2013, 1511.
113. Kuzmenko, A., Atkinson, G.C., Levitskii, S., Zenkin, N., Tenson, T., Hauryliuk, V., Kamenski, P., Mitochondrial translation initiation machinery: Conservation and diversification. Biochimie 100 (2014), 132–140.
114. Kwon, I., Xiang, S., Kato, M., Wu, L., Theodoropoulos, P., Wang, T., Kim, J., Yun, J., Xie, Y., McKnight, S.L., Poly-dipeptides encoded by the C9orf72 repeats bind nucleoli, impede RNA biogenesis, and kill cells. Science 345 (2014), 1139–1145.
115. La Piana, R., Tonduti, D., Gordish Dressman, H., Schmidt, J.L., Murnick, J., Brais, B., Bernard, G., Vanderver, A., Brain magnetic resonance imaging (MRI) pattern recognition in Pol III-related leukodystrophies. J. Child Neurol. 29 (2014), 214–220.
116. Lacerda, R., Menezes, J., Romão, L., More than just scanning: The importance of cap-independent mRNA translation initiation for cellular stress response and cancer. Cell. Mol. Life Sci. 74 (2017), 1659–1680.
117. Lam, W.W.K., Millichap, J.J., Soares, D.C., Chin, R., McLellan, A., FitzPatrick, D.R., Elmslie, F., Lees, M.M., Schaefer, G.B., Abbott, C.M., DDD study. Novel de novo EEF1A2 missense mutations causing epilepsy and intellectual disability. Mol. Genet. Genomic Med. 4 (2016), 465–474.
118. Langstrom, N.S., Anderson, J.P., Lindroos, H.G., Winblad, B., Wallace, W.C., Alzheimer's disease-associated reduction of polysomal mRNA translation. Brain Res. Mol. Brain Res. 5 (1989), 259–269.
119. Lee, S., Wolfraim, L.A., Wang, E., Differential expression of S1 and elongation factor-1 α during rat development. J. Biol. Chem. 268 (1993), 24453–24459.
120. Lee, S., LeBlanc, A., Duttaroy, A., Wang, E., Terminal differentiation-dependent alteration in the expression of translation elongation factor-1 alpha and its sister gene, S1, in neurons. Exp. Cell Res. 219 (1995), 589–597.
121. Lee, J.W., Beebe, K., Nangle, L.A., Jang, J., Longo-Guess, C.M., Cook, S.A., Davisson, M.T., Sundberg, J.P., Schimmel, P., Ackerman, S.L., Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. Nature 443 (2006), 50–55.
122. Lee, K.-H., Zhang, P., Kim, H.J., Mitrea, D.M., Sarkar, M., Freibaum, B.D., Cika, J., Coughlin, M., Messing, J., Molliex, A., et al. C9orf72 dipeptide repeats impair the assembly, dynamics, and function of membrane-less organelles. Cell 167 (2016), 774–788.e17.
123. Leitman, J., Barak, B., Benyair, R., Shenkman, M., Ashery, U., Hartl, F.U., Lederkremer, G.Z., ER stress-induced eIF2-alpha phosphorylation underlies sensitivity of striatal neurons to pathogenic huntingtin. PLoS ONE, 9, 2014, e90803.
124. León, K., Boulo, T., Musnier, A., Morales, J., Gauthier, C., Dupuy, L., Heyne, S., Backofen, R., Poupon, A., Cormier, P., et al. Activation of a GPCR leads to eIF4G phosphorylation at the 5′ cap and to IRES-dependent translation. J. Mol. Endocrinol. 52 (2014), 373–382.
125. Lewerenz, J., Maher, P., Basal levels of eIF2alpha phosphorylation determine cellular antioxidant status by regulating ATF4 and xCT expression. J. Biol. Chem. 284 (2009), 1106–1115.
126. Li, X., Alafuzoff, I., Soininen, H., Winblad, B., Pei, J.J., Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain. FEBS J. 272 (2005), 4211–4220.
127. Ling, J., Roy, H., Ibba, M., Mechanism of tRNA-dependent editing in translational quality control. Proc. Natl. Acad. Sci. USA 104 (2007), 72–77.
128. Liu, E., Knutzen, C.A., Krauss, S., Schweiger, S., Chiang, G.G., Control of mTORC1 signaling by the Opitz syndrome protein MID1. Proc. Natl. Acad. Sci. USA 108 (2011), 8680–8685.
129. Liu, Y., Satz, J.S., Vo, M.-N., Nangle, L.A., Schimmel, P., Ackerman, S.L., Deficiencies in tRNA synthetase editing activity cause cardioproteinopathy. Proc. Natl. Acad. Sci. USA 111 (2014), 17570–17575.
130. Lopes, F., Barbosa, M., Ameur, A., Soares, G., de Sá J., Dias, A.I., Oliveira, G., Cabral, P., Temudo, T., Calado, E., et al. Identification of novel genetic causes of Rett syndrome-like phenotypes. J. Med. Genet. 53 (2016), 190–199.
131. Lu, J., Bergert, M., Walther, A., Suter, B., Double-sieving-defective aminoacyl-tRNA synthetase causes protein mistranslation and affects cellular physiology and development. Nat. Commun., 5, 2014, 5650.
132. Ma, T., Trinh, M.A., Wexler, A.J., Bourbon, C., Gatti, E., Pierre, P., Cavener, D.R., Klann, E., Suppression of eIF2α kinases alleviates Alzheimer's disease-related plasticity and memory deficits. Nat. Neurosci. 16 (2013), 1299–1305.
133. Mackenzie, I.R., Arzberger, T., Kremmer, E., Troost, D., Lorenzl, S., Mori, K., Weng, S.-M., Haass, C., Kretzschmar, H.A., Edbauer, D., Neumann, M., Dipeptide repeat protein pathology in C9ORF72 mutation cases: Clinico-pathological correlations. Acta Neuropathol. 126 (2013), 859–879.
134. Mai, N., Chrzanowska-Lightowlers, Z.M.A., Lightowlers, R.N., The process of mammalian mitochondrial protein synthesis. Cell Tissue Res. 367 (2017), 5–20.
135. Mann, D.M.A., Rollinson, S., Robinson, A., Bennion Callister, J., Thompson, J.C., Snowden, J.S., Gendron, T., Petrucelli, L., Masuda-Suzukake, M., Hasegawa, M., et al. Dipeptide repeat proteins are present in the p62 positive inclusions in patients with frontotemporal lobar degeneration and motor neurone disease associated with expansions in C9ORF72. Acta Neuropathol. Commun., 1, 2013, 68.
136. Martin, I., Kim, J.W., Lee, B.D., Kang, H.C., Xu, J.-C., Jia, H., Stankowski, J., Kim, M.-S., Zhong, J., Kumar, M., et al. Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson's disease. Cell 157 (2014), 472–485.
137. Martinez, F.J., Lee, J.H., Lee, J.E., Blanco, S., Nickerson, E., Gabriel, S., Frye, M., Al-Gazali, L., Gleeson, J.G., Whole exome sequencing identifies a splicing mutation in NSUN2 as a cause of a Dubowitz-like syndrome. J. Med. Genet. 49 (2012), 380–385.
138. Mateyak, M.K., Kinzy, T.G., eEF1A: Thinking outside the ribosome. J. Biol. Chem. 285 (2010), 21209–21213.
139. May, S., Hornburg, D., Schludi, M.H., Arzberger, T., Rentzsch, K., Schwenk, B.M., Grässer, F.A., Mori, K., Kremmer, E., Banzhaf-Strathmann, J., et al. C9orf72 FTLD/ALS-associated Gly-Ala dipeptide repeat proteins cause neuronal toxicity and Unc119 sequestration. Acta Neuropathol. 128 (2014), 485–503.
140. McLaughlin, H.M., Sakaguchi, R., Liu, C., Igarashi, T., Pehlivan, D., Chu, K., Iyer, R., Cruz, P., Cherukuri, P.F., Hansen, N.F., et al., NISC Comparative Sequencing Program. Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy. Am. J. Hum. Genet. 87 (2010), 560–566.
141. McLaughlin, H.M., Sakaguchi, R., Giblin, W., Wilson, T.E., Biesecker, L., Lupski, J.R., Talbot, K., Vance, J.M., Züchner, S., Lee, Y.C., et al., NISC Comparative Sequencing Program. A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N). Hum. Mutat. 33 (2012), 244–253.
142. Merrick, W.C., eIF4F: A retrospective. J. Biol. Chem. 290 (2015), 24091–24099.
143. Meyer-Schuman, R., Antonellis, A., Emerging mechanisms of aminoacyl-tRNA synthetase mutations in recessive and dominant human disease. Hum. Mol. Genet. 26 (2017), R114–R127.
144. Mizielinska, S., Grönke, S., Niccoli, T., Ridler, C.E., Clayton, E.L., Devoy, A., Moens, T., Norona, F.E., Woollacott, I.O.C., Pietrzyk, J., et al. C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins. Science 345 (2014), 1192–1194.
145. Moreno, J.A., Radford, H., Peretti, D., Steinert, J.R., Verity, N., Martin, M.G., Halliday, M., Morgan, J., Dinsdale, D., Ortori, C.A., et al. Sustained translational repression by eIF2α-P mediates prion neurodegeneration. Nature 485 (2012), 507–511.
146. Moreno, J.A., Halliday, M., Molloy, C., Radford, H., Verity, N., Axten, J.M., Ortori, C.A., Willis, A.E., Fischer, P.M., Barrett, D.A., Mallucci, G.R., Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice. Sci. Transl. Med., 5, 2013, 206ra138.
147. Mori, K., Weng, S.-M., Arzberger, T., May, S., Rentzsch, K., Kremmer, E., Schmid, B., Kretzschmar, H.A., Cruts, M., Van Broeckhoven, C., et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science 339 (2013), 1335–1338.
148. Mori, K., Arzberger, T., Grässer, F.A., Gijselinck, I., May, S., Rentzsch, K., Weng, S.-M., Schludi, M.H., van der Zee, J., Cruts, M., et al. Bidirectional transcripts of the expanded C9orf72 hexanucleotide repeat are translated into aggregating dipeptide repeat proteins. Acta Neuropathol. 126 (2013), 881–893.
149. Motley, W.W., Seburn, K.L., Nawaz, M.H., Miers, K.E., Cheng, J., Antonellis, A., Green, E.D., Talbot, K., Yang, X.L., Fischbeck, K.H., Burgess, R.W., Charcot-Marie-Tooth-linked mutant GARS is toxic to peripheral neurons independent of wild-type GARS levels. PLoS Genet., 7, 2011, e1002399.
150. Mouton-Liger, F., Paquet, C., Dumurgier, J., Bouras, C., Pradier, L., Gray, F., Hugon, J., Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2α pathway. Biochim. Biophys. Acta 1822 (2012), 885–896.
151. Nakajima, J., Okamoto, N., Tohyama, J., Kato, M., Arai, H., Funahashi, O., Tsurusaki, Y., Nakashima, M., Kawashima, H., Saitsu, H., et al. De novo EEF1A2 mutations in patients with characteristic facial features, intellectual disability, autistic behaviors and epilepsy. Clin. Genet. 87 (2015), 356–361.
152. Nakayama, T., Wu, J., Galvin-Parton, P., Weiss, J., Andriola, M.R., Hill, R.S., Vaughan, D.J., El-Quessny, M., Barry, B.J., Partlow, J.N., et al. Deficient activity of alanyl-tRNA synthetase underlies an autosomal recessive syndrome of progressive microcephaly, hypomyelination, and epileptic encephalopathy. Hum. Mutat. 38 (2017), 1348–1354.
153. Namavar, Y., Chitayat, D., Barth, P.G., van Ruissen, F., de Wissel, M.B., Poll-The, B.T., Silver, R., Baas, F., TSEN54 mutations cause pontocerebellar hypoplasia type 5. Eur. J. Hum. Genet. 19 (2011), 724–726.
154. Newbery, H.J., Loh, D.H., O'Donoghue, J.E., Tomlinson, V.A.L., Chau, Y.Y., Boyd, J.A., Bergmann, J.H., Brownstein, D., Abbott, C.M., Translation elongation factor eEF1A2 is essential for post-weaning survival in mice. J. Biol. Chem. 282 (2007), 28951–28959.
155. Nijholt, D.A., van Haastert, E.S., Rozemuller, A.J., Scheper, W., Hoozemans, J.J., The unfolded protein response is associated with early tau pathology in the hippocampus of tauopathies. J. Pathol. 226 (2012), 693–702.
156. O'Connor, T., Sadleir, K.R., Maus, E., Velliquette, R.A., Zhao, J., Cole, S.L., Eimer, W.A., Hitt, B., Bembinster, L.A., Lammich, S., et al. Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. Neuron 60 (2008), 988–1009.
157. Oh, S.Y., He, F., Krans, A., Frazer, M., Taylor, J.P., Paulson, H.L., Todd, P.K., RAN translation at CGG repeats induces ubiquitin proteasome system impairment in models of fragile X-associated tremor ataxia syndrome. Hum. Mol. Genet. 24 (2015), 4317–4326.
158. Onuki, R., Bando, Y., Suyama, E., Katayama, T., Kawasaki, H., Baba, T., Tohyama, M., Taira, K., An RNA-dependent protein kinase is involved in tunicamycin-induced apoptosis and Alzheimer's disease. EMBO J. 23 (2004), 959–968.
159. Ortiz, P.A., Ulloque, R., Kihara, G.K., Zheng, H., Kinzy, T.G., Translation elongation factor 2 anticodon mimicry domain mutants affect fidelity and diphtheria toxin resistance. J. Biol. Chem. 281 (2006), 32639–32648.
160. Page, G., Rioux Bilan, A., Ingrand, S., Lafay-Chebassier, C., Pain, S., Perault Pochat, M.C., Bouras, C., Bayer, T., Hugon, J., Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease. Neuroscience 139 (2006), 1343–1354.
161. Pan, T., Adaptive translation as a mechanism of stress response and adaptation. Annu. Rev. Genet. 47 (2013), 121–137.
162. Paquet, C., Bose, A., Polivka, M., Peoc'h, K., Brouland, J.P., Keohane, C., Hugon, J., Gray, F., Neuronal phosphorylated RNA-dependent protein kinase in Creutzfeldt-Jakob disease. J. Neuropathol. Exp. Neurol. 68 (2009), 190–198.
163. Park, S.G., Schimmel, P., Kim, S., Aminoacyl tRNA synthetases and their connections to disease. Proc. Natl. Acad. Sci. USA 105 (2008), 11043–11049.
164. Pavon-Eternod, M., Gomes, S., Geslain, R., Dai, Q., Rosner, M.R., Pan, T., tRNA over-expression in breast cancer and functional consequences. Nucleic Acids Res. 37 (2009), 7268–7280.
165. Pearce, S., Nezich, C.L., Spinazzola, A., Mitochondrial diseases: Translation matters. Mol. Cell. Neurosci. 55 (2013), 1–12.
166. Peel, A.L., Bredesen, D.E., Activation of the cell stress kinase PKR in Alzheimer's disease and human amyloid precursor protein transgenic mice. Neurobiol. Dis. 14 (2003), 52–62.
167. Peel, A.L., Rao, R.V., Cottrell, B.A., Hayden, M.R., Ellerby, L.M., Bredesen, D.E., Double-stranded RNA-dependent protein kinase, PKR, binds preferentially to Huntington's disease (HD) transcripts and is activated in HD tissue. Hum. Mol. Genet. 10 (2001), 1531–1538.
168. Pelassa, I., Fiumara, F., Differential occurrence of interactions and interaction domains in proteins containing homopolymeric amino acid repeats. Front. Genet., 6, 2015, 345.
169. Pisareva, V.P., Skabkin, M.A., Hellen, C.U.T., Pestova, T.V., Pisarev, A.V., Dissociation by Pelota, Hbs1 and ABCE1 of mammalian vacant 80S ribosomes and stalled elongation complexes. EMBO J. 30 (2011), 1804–1817.
170. Prabhakar, A., Choi, J., Wang, J., Petrov, A., Puglisi, J.D., Dynamic basis of fidelity and speed in translation: Coordinated multistep mechanisms of elongation and termination. Protein Sci. 26 (2017), 1352–1362.
171. Puffenberger, E.G., Jinks, R.N., Sougnez, C., Cibulskis, K., Willert, R.A., Achilly, N.P., Cassidy, R.P., Fiorentini, C.J., Heiken, K.F., Lawrence, J.J., et al. Genetic mapping and exome sequencing identify variants associated with five novel diseases. PLoS ONE, 7, 2012, e28936.
172. Radford, H., Moreno, J.A., Verity, N., Halliday, M., Mallucci, G.R., PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementia. Acta Neuropathol. 130 (2015), 633–642.
173. Richter, J.D., Coller, J., Pausing on polyribosomes: Make way for elongation in translational control. Cell 163 (2015), 292–300.
174. Rudolph, K.L.M., Schmitt, B.M., Villar, D., White, R.J., Marioni, J.C., Kutter, C., Odom, D.T., Codon-driven translational efficiency is stable across diverse mammalian cell states. PLoS Genet., 12, 2016, e1006024.
175. Saffert, P., Adamla, F., Schieweck, R., Atkins, J.F., Ignatova, Z., An Expanded CAG Repeat in Huntingtin Causes +1 Frameshifting. J. Biol. Chem. 291 (2016), 18505–18513.
176. Saitsu, H., Osaka, H., Sasaki, M., Takanashi, J., Hamada, K., Yamashita, A., Shibayama, H., Shiina, M., Kondo, Y., Nishiyama, K., et al. Mutations in POLR3A and POLR3B encoding RNA Polymerase III subunits cause an autosomal-recessive hypomyelinating leukoencephalopathy. Am. J. Hum. Genet. 89 (2011), 644–651.
177. Sandbaken, M.G., Culbertson, M.R., Mutations in elongation factor EF-1 alpha affect the frequency of frameshifting and amino acid misincorporation in Saccharomyces cerevisiae. Genetics 120 (1988), 923–934.
178. Sasarman, F., Thiffault, I., Weraarpachai, W., Salomon, S., Maftei, C., Gauthier, J., Ellazam, B., Webb, N., Antonicka, H., Janer, A., et al. The 3′ addition of CCA to mitochondrial tRNASer(AGY) is specifically impaired in patients with mutations in the tRNA nucleotidyl transferase TRNT1. Hum. Mol. Genet. 24 (2015), 2841–2847.
179. Sauna, Z.E., Kimchi-Sarfaty, C., Understanding the contribution of synonymous mutations to human disease. Nat. Rev. Genet. 12 (2011), 683–691.
180. Schaffer, A.E., Eggens, V.R.C., Caglayan, A.O., Reuter, M.S., Scott, E., Coufal, N.G., Silhavy, J.L., Xue, Y., Kayserili, H., Yasuno, K., et al. CLP1 founder mutation links tRNA splicing and maturation to cerebellar development and neurodegeneration. Cell 157 (2014), 651–663.
181. Schimmel, P., Mistranslation and its control by tRNA synthetases. Philos. Trans. R. Soc. Lond. B Biol. Sci. 366 (2011), 2965–2971.
182. Schimmel, P., The emerging complexity of the tRNA world: Mammalian tRNAs beyond protein synthesis. Nat. Rev. Mol. Cell Biol., 2017, 10.1038/nrm.2017.77 Published online September 6, 2017.
183. Schludi, M.H., May, S., Grässer, F.A., Rentzsch, K., Kremmer, E., Küpper, C., Klopstock, T., Arzberger, T., Edbauer, D. German Consortium for Frontotemporal Lobar Degeneration, Bavarian Brain Banking Alliance. Distribution of dipeptide repeat proteins in cellular models and C9orf72 mutation cases suggests link to transcriptional silencing. Acta Neuropathol. 130 (2015), 537–555.
184. Schmitt, B.M., Rudolph, K.L.M., Karagianni, P., Fonseca, N.A., White, R.J., Talianidis, I., Odom, D.T., Marioni, J.C., Kutter, C., High-resolution mapping of transcriptional dynamics across tissue development reveals a stable mRNA-tRNA interface. Genome Res. 24 (2014), 1797–1807.
185. Schwartz, M.H., Pan, T., Function and origin of mistranslation in distinct cellular contexts. Crit. Rev. Biochem. Mol. Biol. 52 (2017), 205–219.
186. Scoles, D.R., Ho, M.H.T., Dansithong, W., Pflieger, L.T., Petersen, L.W., Thai, K.K., Pulst, S.M., Repeat associated non-AUG translation (RAN translation) dependent on sequence downstream of the ATXN2 CAG repeat. PLoS ONE, 10, 2015, e0128769.
187. Seburn, K.L., Nangle, L.A., Cox, G.A., Schimmel, P., Burgess, R.W., An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth 2D mouse model. Neuron 51 (2006), 715–726.
188. Sellier, C., Buijsen, R.A.M., He, F., Natla, S., Jung, L., Tropel, P., Gaucherot, A., Jacobs, H., Meziane, H., Vincent, A., et al. Translation of expanded CGG repeats into FMRpolyG is pathogenic and may contribute to Fragile X tremor ataxia syndrome. Neuron 93 (2017), 331–347.
189. Shao, S., von der Malsburg, K., Hegde, R.S., Listerin-dependent nascent protein ubiquitination relies on ribosome subunit dissociation. Mol. Cell 50 (2013), 637–648.
190. Shigematsu, M., Honda, S., Kirino, Y., Transfer RNA as a source of small functional RNA. J Mol Biol Mol Imaging 1 (2014), 1–15.
191. Shimojima, K., Shimada, S., Tamasaki, A., Akaboshi, S., Komoike, Y., Saito, A., Furukawa, T., Yamamoto, T., Novel compound heterozygous mutations of POLR3A revealed by whole-exome sequencing in a patient with hypomyelination. Brain Dev. 36 (2014), 315–321.
192. Shoemaker, C.J., Eyler, D.E., Green, R., Dom34:Hbs1 promotes subunit dissociation and peptidyl-tRNA drop-off to initiate no-go decay. Science 330 (2010), 369–372.
193. Simons, C., Griffin, L.B., Helman, G., Golas, G., Pizzino, A., Bloom, M., Murphy, J.L.P., Crawford, J., Evans, S.H., Topper, S., et al. Loss-of-function alanyl-tRNA synthetase mutations cause an autosomal-recessive early-onset epileptic encephalopathy with persistent myelination defect. Am. J. Hum. Genet. 96 (2015), 675–681.
194. Sleigh, J.N., Dawes, J.M., West, S.J., Wei, N., Spaulding, E.L., Gómez-Martín, A., Zhang, Q., Burgess, R.W., Cader, M.Z., Talbot, K., et al. Trk receptor signaling and sensory neuron fate are perturbed in human neuropathy caused by Gars mutations. Proc. Natl. Acad. Sci. USA 114 (2017), E3324–E3333.
195. Sobala, A., Hutvagner, G., Transfer RNA-derived fragments: Origins, processing, and functions. Wiley Interdiscip. Rev. RNA 2 (2011), 853–862.
196. Sobczak, K., de Mezer, M., Michlewski, G., Krol, J., Krzyzosiak, W.J., RNA structure of trinucleotide repeats associated with human neurological diseases. Nucleic Acids Res. 31 (2003), 5469–5482.
197. Sonenberg, N., Hinnebusch, A.G., Regulation of translation initiation in eukaryotes: Mechanisms and biological targets. Cell 136 (2009), 731–745.
198. Stum, M., McLaughlin, H.M., Kleinbrink, E.L., Miers, K.E., Ackerman, S.L., Seburn, K.L., Antonellis, A., Burgess, R.W., An assessment of mechanisms underlying peripheral axonal degeneration caused by aminoacyl-tRNA synthetase mutations. Mol. Cell. Neurosci. 46 (2011), 432–443.
199. Stutzbach, L.D., Xie, S.X., Naj, A.C., Albin, R., Gilman, S., Lee, V.M., Trojanowski, J.Q., Devlin, B., Schellenberg, G.D., PSP Genetics Study Group. The unfolded protein response is activated in disease-affected brain regions in progressive supranuclear palsy and Alzheimer's disease. Acta Neuropathol. Commun., 1, 2013, 31.
200. Taft, R.J., Vanderver, A., Leventer, R.J., Damiani, S.A., Simons, C., Grimmond, S.M., Miller, D., Schmidt, J., Lockhart, P.J., Pope, K., et al. Mutations in DARS cause hypomyelination with brain stem and spinal cord involvement and leg spasticity. Am. J. Hum. Genet. 92 (2013), 774–780.
201. Tain, L.S., Mortiboys, H., Tao, R.N., Ziviani, E., Bandmann, O., Whitworth, A.J., Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron loss. Nat. Neurosci. 12 (2009), 1129–1135.
202. Takanashi, J., Osaka, H., Saitsu, H., Sasaki, M., Mori, H., Shibayama, H., Tanaka, M., Nomura, Y., Terao, Y., Inoue, K., et al. Different patterns of cerebellar abnormality and hypomyelination between POLR3A and POLR3B mutations. Brain Dev. 36 (2014), 259–263.
203. Tao, Z., Wang, H., Xia, Q., Li, K., Li, K., Jiang, X., Xu, G., Wang, G., Ying, Z., Nucleolar stress and impaired stress granule formation contribute to C9orf72 RAN translation-induced cytotoxicity. Hum. Mol. Genet. 24 (2015), 2426–2441.
204. Tétreault, M., Choquet, K., Orcesi, S., Tonduti, D., Balottin, U., Teichmann, M., Fribourg, S., Schiffmann, R., Brais, B., Vanderver, A., Bernard, G., Recessive mutations in POLR3B, encoding the second largest subunit of Pol III, cause a rare hypomyelinating leukodystrophy. Am. J. Hum. Genet. 89 (2011), 652–655.
205. Thiaville, P.C., Legendre, R., Rojas-Benítez, D., Baudin-Baillieu, A., Hatin, I., Chalancon, G., Glavic, A., Namy, O., de Crécy-Lagard, V., Global translational impacts of the loss of the tRNA modification t(6)A in yeast. Microb. Cell 3 (2016), 29–45.
206. Thiffault, I., Wolf, N.I., Forget, D., Guerrero, K., Tran, L.T., Choquet, K., Lavallée-Adam, M., Poitras, C., Brais, B., Yoon, G., et al. Recessive mutations in POLR1C cause a leukodystrophy by impairing biogenesis of RNA polymerase III. Nat. Commun., 6, 2015, 7623.
207. Thoreen, C.C., The molecular basis of mTORC1-regulated translation. Biochem. Soc. Trans. 45 (2017), 213–221.
208. Todd, P.K., Oh, S.Y., Krans, A., He, F., Sellier, C., Frazer, M., Renoux, A.J., Chen, K.C., Scaglione, K.M., Basrur, V., et al. CGG repeat-associated translation mediates neurodegeneration in fragile X tremor ataxia syndrome. Neuron 78 (2013), 440–455.
209. Torres, A.G., Batlle, E., Ribas de Pouplana, L., Role of tRNA modifications in human diseases. Trends Mol. Med. 20 (2014), 306–314.
210. Toulouse, A., Au-Yeung, F., Gaspar, C., Roussel, J., Dion, P., Rouleau, G.A., Ribosomal frameshifting on MJD-1 transcripts with long CAG tracts. Hum. Mol. Genet. 14 (2005), 2649–2660.
211. Trinh, M.A., Klann, E., Translational control by eIF2α kinases in long-lasting synaptic plasticity and long-term memory. Neurobiol. Learn. Mem. 105 (2013), 93–99.
212. Trinh, M.A., Ma, T., Kaphzan, H., Bhattacharya, A., Antion, M.D., Cavener, D.R., Hoeffer, C.A., Klann, E., The eIF2α kinase PERK limits the expression of hippocampal metabotropic glutamate receptor-dependent long-term depression. Learn. Mem. 21 (2014), 298–304.
213. Unterberger, U., Höftberger, R., Gelpi, E., Flicker, H., Budka, H., Voigtländer, T., Endoplasmic reticulum stress features are prominent in Alzheimer disease but not in prion diseases in vivo. J. Neuropathol. Exp. Neurol. 65 (2006), 348–357.
214. van der Voorn, J.P., van Kollenburg, B., Bertrand, G., Van Haren, K., Scheper, G.C., Powers, J.M., van der Knaap, M.S., The unfolded protein response in vanishing white matter disease. J. Neuropathol. Exp. Neurol. 64 (2005), 770–775.
215. van Es, M.A., Schelhaas, H.J., van Vught, P.W.J., Ticozzi, N., Andersen, P.M., Groen, E.J.N., Schulte, C., Blauw, H.M., Koppers, M., Diekstra, F.P., et al. Angiogenin variants in Parkinson disease and amyotrophic lateral sclerosis. Ann. Neurol. 70 (2011), 964–973.
216. van Kollenburg, B., van Dijk, J., Garbern, J., Thomas, A.A.M., Scheper, G.C., Powers, J.M., van der Knaap, M.S., Glia-specific activation of all pathways of the unfolded protein response in vanishing white matter disease. J. Neuropathol. Exp. Neurol. 65 (2006), 707–715.
217. van Meel, E., Wegner, D.J., Cliften, P., Willing, M.C., White, F.V., Kornfeld, S., Cole, F.S., Rare recessive loss-of-function methionyl-tRNA synthetase mutations presenting as a multi-organ phenotype. BMC Med. Genet., 14, 2013, 106.
218. Veeramah, K.R., Johnstone, L., Karafet, T.M., Wolf, D., Sprissler, R., Salogiannis, J., Barth-Maron, A., Greenberg, M.E., Stuhlmann, T., Weinert, S., et al. Exome sequencing reveals new causal mutations in children with epileptic encephalopathies. Epilepsia 54 (2013), 1270–1281.
219. Vieira, F.G., Ping, Q., Moreno, A.J., Kidd, J.D., Thompson, K., Jiang, B., Lincecum, J.M., Wang, M.Z., De Zutter, G.S., Tassinari, V.R., et al. Guanabenz Treatment Accelerates Disease in a Mutant SOD1 Mouse Model of ALS. PLoS ONE, 10, 2015, e0135570.
220. Vijgenboom, E., Bosch, L., Translational frameshifts induced by mutant species of the polypeptide chain elongation factor Tu of Escherichia coli. J. Biol. Chem. 264 (1989), 13012–13017.
221. Wang, L., Popko, B., Roos, R.P., The unfolded protein response in familial amyotrophic lateral sclerosis. Hum. Mol. Genet. 20 (2011), 1008–1015.
222. Wang, L., Popko, B., Tixier, E., Roos, R.P., Guanabenz, which enhances the unfolded protein response, ameliorates mutant SOD1-induced amyotrophic lateral sclerosis. Neurobiol. Dis. 71 (2014), 317–324.
223. Wang, L., Popko, B., Roos, R.P., An enhanced integrated stress response ameliorates mutant SOD1-induced ALS. Hum. Mol. Genet. 23 (2014), 2629–2638.
224. Wen, X., Tan, W., Westergard, T., Krishnamurthy, K., Markandaiah, S.S., Shi, Y., Lin, S., Shneider, N.A., Monaghan, J., Pandey, U.B., et al. Antisense proline-arginine RAN dipeptides linked to C9ORF72-ALS/FTD form toxic nuclear aggregates that initiate in vitro and in vivo neuronal death. Neuron 84 (2014), 1213–1225.
225. Willis, M.S., Patterson, C., Proteotoxicity and cardiac dysfunction—Alzheimer's disease of the heart?. N. Engl. J. Med. 368 (2013), 455–464.
226. Wolf, N.I., Salomons, G.S., Rodenburg, R.J., Pouwels, P.J.W., Schieving, J.H., Derks, T.G.J., Fock, J.M., Rump, P., van Beek, D.M., van der Knaap, M.S., Waisfisz, Q., Mutations in RARS cause hypomyelination. Ann. Neurol. 76 (2014), 134–139.
227. Wu, D., Yu, W., Kishikawa, H., Folkerth, R.D., Iafrate, A.J., Shen, Y., Xin, W., Sims, K., Hu, G.F., Angiogenin loss-of-function mutations in amyotrophic lateral sclerosis. Ann. Neurol. 62 (2007), 609–617.
228. Xue, S., Barna, M., Specialized ribosomes: A new frontier in gene regulation and organismal biology. Nat. Rev. Mol. Cell Biol. 13 (2012), 355–369.
229. Yamakawa, M., Ito, D., Honda, T., Kubo, K., Noda, M., Nakajima, K., Suzuki, N., Characterization of the dipeptide repeat protein in the molecular pathogenesis of c9FTD/ALS. Hum. Mol. Genet. 24 (2015), 1630–1645.
230. Yamasaki, S., Ivanov, P., Hu, G.-F., Anderson, P., Angiogenin cleaves tRNA and promotes stress-induced translational repression. J. Cell Biol. 185 (2009), 35–42.
231. Yang, W., Zhou, X., Zimmermann, H.R., Cavener, D.R., Klann, E., Ma, T., Repression of the eIF2α kinase PERK alleviates mGluR-LTD impairments in a mouse model of Alzheimer's disease. Neurobiol. Aging 41 (2016), 19–24.
232. Zaher, H.S., Green, R., Fidelity at the molecular level: lessons from protein synthesis. Cell 136 (2009), 746–762.
233. Zhang, X., Ling, J., Barcia, G., Jing, L., Wu, J., Barry, B.J., Mochida, G.H., Hill, R.S., Weimer, J.M., Stein, Q., et al. Mutations in QARS, encoding glutaminyl-tRNA synthetase, cause progressive microcephaly, cerebral-cerebellar atrophy, and intractable seizures. Am. J. Hum. Genet. 94 (2014), 547–558.
234. Zhang, Y.-J., Jansen-West, K., Xu, Y.-F., Gendron, T.F., Bieniek, K.F., Lin, W.-L., Sasaguri, H., Caulfield, T., Hubbard, J., Daughrity, L., et al. Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress. Acta Neuropathol. 128 (2014), 505–524.
235. Zhao, T., Hong, Y., Li, X.-J., Li, S.-H., Subcellular clearance and accumulation of Huntington disease protein: A mini-review. Front. Mol. Neurosci., 9, 2016, 27.
236. Zhu, P.J., Huang, W., Kalikulov, D., Yoo, J.W., Placzek, A.N., Stoica, L., Zhou, H., Bell, J.C., Friedlander, M.J., Krnjević K., et al. Suppression of PKR promotes network excitability and enhanced cognition by interferon-γ-mediated disinhibition. Cell 147 (2011), 1384–1396.
237. Zhu, Z., Yan, J., Jiang, W., Yao, X.G., Chen, J., Chen, L., Li, C., Hu, L., Jiang, H., Shen, X., Arctigenin effectively ameliorates memory impairment in Alzheimer's disease model mice targeting both β-amyloid production and clearance. J. Neurosci. 33 (2013), 13138–13149.
238. Zu, T., Gibbens, B., Doty, N.S., Gomes-Pereira, M., Huguet, A., Stone, M.D., Margolis, J., Peterson, M., Markowski, T.W., Ingram, M.A.C., et al. Non-ATG-initiated translation directed by microsatellite expansions. Proc. Natl. Acad. Sci. USA 108 (2011), 260–265.
239. Zu, T., Liu, Y., Bañez-Coronel, M., Reid, T., Pletnikova, O., Lewis, J., Miller, T.M., Harms, M.B., Falchook, A.E., Subramony, S.H., et al. RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia. Proc. Natl. Acad. Sci. USA 110 (2013), E4968–E4977.
240. Zu, T., Cleary, J.D., Liu, Y., Bañez-Coronel, M., Bubenik, J.L., Ayhan, F., Ashizawa, T., Xia, G., Clark, H.B., Yachnis, A.T., et al. RAN translation regulated by muscleblind proteins in myotonic dystrophy type 2. Neuron 95 (2017), 1292–1305.e5.